The lack of human otic cell models represents a significant roadblock hampering the development of drug-based or cell-based therapies. Hearing impairment is the most frequent
human sensory deficit and is mainly caused by the irreversible loss of neurosensory cells in the cochlea.
OTOSTEM addressed this urgent and unmet medical need for causal hearing loss therapies by focusing on human stem cell technology.